Curalin
Commercial- Indications
- Type 2 diabetes
Company intelligence / Profile preview
CuraLife’s lead product, CuraLin, is a clinically validated herbal supplement shown in randomized controlled trials to significantly reduce HbA1c as an add-on therapy for adults with type 2 diabetes. The company’s new product Curaslim targets weight loss by naturally boosting GLP‑1 production and has demonstrated clinically validated results for sustainable weight management. Both products are supported by digital health tools and personalized care models[1][3][4][5].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CuraLife.